Back to Search Start Over

Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society

Source :
Business Wire. October 1, 2024
Publication Year :
2024

Abstract

BOULDER, Colo. -- Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced its participation at the 29th International Annual Congress of the World Muscle Society (WMS) [...]

Subjects

Subjects :
Therapeutics Inc. -- Political activity
Medical research -- Political aspects
Medicine, Experimental -- Political aspects
Societies -- Political aspects
Associations, institutions, etc. -- Political aspects
Business
Business, international

Details

Language :
English
Database :
Gale General OneFile
Journal :
Business Wire
Publication Type :
News
Accession number :
edsgcl.810711871

Tools

Authors Abstract Subjects Details